NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.

Nadeem R Abu-Rustum,Catheryn M Yashar,Rebecca Arend,Emma Barber, Kristin Bradley,Rebecca Brooks,Susana M Campos,Junzo Chino, Hye Sook Chon,Marta Ann Crispens,Shari Damast,Christine M Fisher,Peter Frederick,David K Gaffney, Stephanie Gaillard,Robert Giuntoli, Scott Glaser, Jordan Holmes,Brooke E Howitt,Jayanthi Lea, Gina Mantia-Smaldone,Andrea Mariani,David Mutch,Christa Nagel, Larissa Nekhlyudov,Mirna Podoll, Kerry Rodabaugh,Ritu Salani,John Schorge, Jean Siedel,Rachel Sisodia,Pamela Soliman,Stefanie Ueda,Renata Urban,Emily Wyse,Nicole R McMillian, Shaili Aggarwal,Sara Espinosa

Journal of the National Comprehensive Cancer Network : JNCCN（2023）

引用 0|浏览7

暂无评分

摘要

The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要